Top news of the week: 01.09.2020.
#BioTech #earlystage #venturecapital #natural #partners #tumeric #curcumin
Healthcare
FDA Culpa, Tricida Trips, Freenome’s Funding & More #BioTech via https://t.co/2sI0UxJbpn https://t.co/mG1NV82vwH
OpenBiotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More
Among the casualties of the COVID-19 pandemic: the credibility of government agencies entrusted with protecting public health. The FDA this week granted
Tricida sinks as FDA rejection raises prospect of new trial
The FDA has rejected Tricida’s filing for approval of a treatment for metabolic acidosis in patients with chronic kidney disease. Tricida said it may need to run another clinical trial to ...
The Inside Story Of Biotech’s Barnum And His Covid Cures #BioTech via https://t.co/2sI0UxrA0N https://t.co/uM2GGMP838
OpenBillionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat “the crisis of our time.”
Billionaire Patrick Soon-Shiong’s radical cancer treatments made him one of the wealthiest physicians on Earth. Now the master of medical marketing believes his drug therapies could defeat ...
RT @ASPET: Thousands of Coronavirus Infections Stemmed from a Biotech Event: https://t.co/A2syeWwrRe
OpenThousands of Coronavirus Infections Stemmed from a Biotech Event
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
RT @huguitomc: Nice investment thesis Civilization Ventures @CivilizationVC
#biotech #earlystage #venturecapital https://t.co/y5TuTQIk0M
OpenA small VC group expands its hunt for inspired biotech founders in need of seed cash
Civilization Ventures, a California-based VC fund that successfully bet on biotechs Rocket Pharmaceuticals and Singular Bio a few years ago, is bringing forth its next round of investments. ...
AstraZeneca starts phase 1 of antibodies that could protect against COVID-19 for 6 months https://t.co/40iJ6Yq1nY
OpenAstraZeneca starts phase 1 of antibodies that could protect against COVID-19 for 6 months
AstraZeneca has started a phase 1 clinical trial of its two-antibody cocktail against COVID-19. The 48-subject trial is set to deliver data later this year and set AstraZeneca up to ...
Emerging Growth Report reveals a hidden gem in the Biotech Space #BioTech via https://t.co/2sI0UxJbpn https://t.co/kcUG3vUPfS
OpenEmerging Growth Report reveals a hidden gem in the Biotech Space
Emerging Growth Report reveals a hidden gem in the Biotech Space . PetVivo (OTCQB: PETV) is an emerging biomedical device company leveraging the investments in the human biomaterials and ...
RT @NutriPR_: IFF Health partners with Dolcas Biotech to market curcumin ingredient https://t.co/y0FWhKWGrG via @FoodIng1st #partners #curcumin #natural #tumeric
OpenIFF Health partners with Dolcas Biotech to market curcumin ingredient
26 Aug 2020 --- IFF Health and DolCas Biotech have partnered for the sale and marketing of Curcugen, dubbed as a “next-gen,” all-natural turmeric extract for supplements, food and ...